| 产品详情 |
| Edit |   |
|---|
| Product Name | LeukinFeron, Recombinant, Human (LF) |
|---|
| Description | Human LeukinFeron is a combined preparation of natural cytokines involved in cellular reactions elimination of pathogen (antigen). Treatment with LeukinFeron results in a reduced frequency of side effects caused by prospidine therapy. Human LeukinFeron in the combined therapy of Kaposi's sarcoma leads to a considerable improvement of the initially abnormal levels of immunocompetent and phagocytizing cells. A single dose of human LeukinFeron is produced from 1 million leukocytes isolated from donor's blood contains natural IFN-a 10,000IU and a complex of cytokines from the first phase of the immune response at their natural ratio: IL-6, IL-12, TNF-a, MIF and LIF. LF activates expression of HLA-Dr antigens on human immune effectors and improve immune recognition. LF provides the normalizing action on CD4/CD8 cells interaction and cytokine production by immunocompetent cells that is important for immunoreactivity. LF is applied for the treatment of many viral diseases, bacterial infection |
|---|
| Size | 10000IU |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Human LeukinFeron, LeukinFeron, h-LeukinFeron, rh-LeukinFeron, recombinant human LeukinFeron.recombinant insulin, insulin |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 220005 |
|---|
| Price | |
|---|
| Order / More Info | LeukinFeron, Recombinant, Human (LF) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|